000 01587 a2200397 4500
005 20250513103303.0
264 0 _c19970306
008 199703s 0 0 eng d
022 _a0893-133X
024 7 _a10.1016/0893-133X(95)00242-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHoff, A L
245 0 0 _aThe effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients.
_h[electronic resource]
260 _bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
_cOct 1996
300 _a361-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aClozapine
_xtherapeutic use
650 0 4 _aCognition
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInpatients
650 0 4 _aMale
650 0 4 _aPrognosis
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aSchizophrenic Psychology
700 1 _aFaustman, W O
700 1 _aWieneke, M
700 1 _aEspinoza, S
700 1 _aCosta, M
700 1 _aWolkowitz, O
700 1 _aCsernansky, J G
773 0 _tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
_gvol. 15
_gno. 4
_gp. 361-9
856 4 0 _uhttps://doi.org/10.1016/0893-133X(95)00242-6
_zAvailable from publisher's website
999 _c8880648
_d8880648